Preclinical characterization of CK-4021586, a new class of cardiac myosin inhibitors for the treatment of hypertrophic cardiomyopathy
Sankar Sarkar, Saswata, Hartman, James J., Hwee, Darren T., Chuang, Chihyuan, Cremin, Peadar, deRosier, Andre, Edell, Samantha, Madhvani, Roshni, Wu, Yangsong, Yco, Lisette, Zamora, Jeanelle, Murphy, Anne, Morgan, Bradley P., Malik, Fady I.
Published in Biophysical journal (10.02.2023)
Published in Biophysical journal (10.02.2023)
Get full text
Journal Article
Reduced Fluorescence Lifetime Heterogeneity of 5-Fluorotryptophan in Comparison to Tryptophan in Proteins: Implication for Resonance Energy Transfer Experiments
Sarkar, Saswata Sankar, Udgaonkar, Jayant B, Krishnamoorthy, G
Published in The journal of physical chemistry. B (09.06.2011)
Published in The journal of physical chemistry. B (09.06.2011)
Get full text
Journal Article
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy
Hartman, James J, Hwee, Darren T, Robert-Paganin, Julien, Chuang, Chihyuan, Chin, Eva R, Edell, Samantha, Lee, Ken H, Madhvani, Roshni, Paliwal, Preeti, Pernier, Julien, Sarkar, Saswata Sankar, Schaletzky, Julia, Schauer, Kristine, Taheri, Khanha D, Wang, Jingying, Wehri, Eddie, Wu, Yangsong, Houdusse, Anne, Morgan, Bradley P, Malik, Fady I
Published in Nature cardiovascular research (01.08.2024)
Published in Nature cardiovascular research (01.08.2024)
Get more information
Journal Article